(DCCHAS) UBS (Irl) Fund Solutions – - Ratings and Ratios

Exchange: SW • Country: Switzerland • Currency: CHF • Type: Etf • ISIN: IE00B598DX38

Commodities, Currencies, Energy, Metals, Indices

Description: DCCHAS UBS (Irl) Fund Solutions –

Ticker Symbol: DCCHAS Exchange: SW Type: ETF Country Origin: Switzerland ETF Category: Commodities - Broad Basket Average Volume 20d: 2595 Last Price: 50.90 SMA 20: 51.38 SMA 50: 50.22 SMA 200: 48.71 ATR: 0.44 AUM: 75.41M CHF

The UBS Irl Fund Solutions plc – Bloomberg Commodity Index SF UCITS ETF (hedged to CHF) A-acc (SW:DCCHAS) is a Swiss-domiciled ETF designed to provide exposure to a broad range of commodities while hedging currency risk for CHF investors. It tracks the Bloomberg Commodity Index, which includes futures contracts on physical commodities such as energy, agriculture, metals, and livestock. The fund is structured as a UCITS-compliant ETF, ensuring transparency and regulatory compliance for European investors.

From a technical perspective, the ETF is currently trading slightly below its 20-day simple moving average (SMA) of 51.38, with a last price of 50.90. The 50-day SMA of 50.22 suggests a neutral short-term trend, while the 200-day SMA of 48.71 indicates a longer-term upward trajectory. The Average True Range (ATR) of 0.44 reflects relatively low volatility, making it a stable choice for risk-averse investors.

The funds assets under management (AUM) of 75.41M CHF indicate a moderate size, sufficient to ensure liquidity while avoiding excessive market impact. The average daily trading volume of 2595 shares highlights its niche appeal, primarily catering to institutional or strategic investors seeking diversified commodity exposure.

3-Month Forecast: Based on the technical and fundamental data, the ETF is expected to trade within a narrow range of 49.50 to 52.50 CHF over the next three months. The SMA 20 and SMA 50 will act as key resistance levels, while the SMA 200 will provide support. The low ATR of 0.44 suggests minimal price fluctuations, with potential upside driven by strengthening commodity prices amid macroeconomic recovery. However, downside risks remain tied to global inflationary pressures and geopolitical instability impacting commodity markets.

Additional Sources for DCCHAS ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

DCCHAS ETF Overview

Market Cap in USD 96m
Category Commodities - Broad Basket
TER 0.20%
IPO / Inception 2011-04-06

DCCHAS ETF Ratings

Growth Rating 41.4
Fundamental -
Dividend Rating 0.0
Rel. Strength 1.41
Analysts -
Fair Price Momentum 47.08 CHF
Fair Price DCF -

DCCHAS Dividends

Currently no dividends paid

DCCHAS Growth Ratios

Growth Correlation 3m 48%
Growth Correlation 12m 70.5%
Growth Correlation 5y 34.8%
CAGR 5y 9.06%
CAGR/Max DD 5y 0.29
Sharpe Ratio 12m 1.22
Alpha -5.06
Beta 0.289
Volatility 16.04%
Current Volume 0.3k
Average Volume 20d 1.4k
What is the price of DCCHAS shares?
As of July 06, 2025, the stock is trading at CHF 50.49 with a total of 274 shares traded.
Over the past week, the price has changed by +0.46%, over one month by +0.94%, over three months by +3.27% and over the past year by +1.18%.
Is UBS (Irl) Fund Solutions – a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, UBS (Irl) Fund Solutions – (SW:DCCHAS) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 41.38 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DCCHAS is around 47.08 CHF . This means that DCCHAS is currently overvalued and has a potential downside of -6.75%.
Is DCCHAS a buy, sell or hold?
UBS (Irl) Fund Solutions – has no consensus analysts rating.
What are the forecasts for DCCHAS share price target?
According to our own proprietary Forecast Model, DCCHAS UBS (Irl) Fund Solutions – will be worth about 51.8 in July 2026. The stock is currently trading at 50.49. This means that the stock has a potential upside of +2.63%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 51.8 2.6%